These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2646838)

  • 1. [Computer-assisted geometric measuring technic in coronary angiography interval studies: results of initial angiograms of the International Nifedipine Trial of Anti-atherosclerotic Therapy (INTACT) study].
    Jost S; Deckers J; Nellessen U; Rafflenbeul W; Hecker H; Reiber JH; Lippolt P; Hugenholtz PG; Lichtlen PR
    Z Kardiol; 1989 Jan; 78(1):23-32. PubMed ID: 2646838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International nifedipine trial on anti-atherosclerotic therapy (INTACT)--methodologic implications and results of a coronary angiographic follow-up study using computer-assisted film analysis.
    Jost S; Deckers J; Rafflenbeul W; Hecker H; Reiber JH; Nikutta P; Wiese B; Hugenholtz P; Lichtlen P
    Int J Card Imaging; 1990-1991; 6(2):117-33. PubMed ID: 2097305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of quantitative coronary angiography using the CAAS system: preliminary results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy).
    Jost S; Deckers JW; Nellessen U; Rafflenbeul W; Hecker H; Reiber JH; Hugenholtz PG; Lichtlen PR
    Int J Card Imaging; 1988; 3(2-3):75-86. PubMed ID: 3049846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Features of the angiographic evaluation of the INTACT study. International Nifedipine Trial on Antiatherosclerotic Therapy.
    Jost S; Deckers J; Rafflenbeul W; Hecker H; Nellessen U; Wiese B; Hugenholtz PG; Lichtlen PR
    Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():1037-45. PubMed ID: 2076391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of coronary stenoses is related to baseline severity--a prospective quantitative angiographic analysis in patients with moderate coronary disease. INTACT Investigators. International Nifedipine Trial on Antiatherosclerotic Therapy.
    Jost S; Deckers JW; Nikutta P; Wiese B; Rafflenbeul W; Hecker H; Lippolt P; Lichtlen PR
    Eur Heart J; 1994 May; 15(5):648-53. PubMed ID: 8056005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative angiographic follow-up studies on the development of coronary artery disease: which coronary segments should be analyzed? Experience from INTACT.
    Jost S; Deckers J; Rafflenbeul W; Reiber JH; Nikutta P; Wiese B; Hecker H; Lippolt P; Riedel M; Nolte CW
    Int J Card Imaging; 1993 Mar; 9(1):29-37. PubMed ID: 8491998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy).
    Lichtlen PR; Hugenholtz PG; Rafflenbeul W; Hecker H; Jost S; Nikutta P; Deckers JW
    Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():1047-68. PubMed ID: 2076392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the selection of angiographic projections on the results of coronary angiographic follow-up trials. International Nifedipine Trial on Antiatherosclerotic Therapy Investigators.
    Jost S; Deckers J; Nikutta P; Reiber JH; Rafflenbeul W; Wiese B; Hecker H; Lichtlen P
    Am Heart J; 1995 Sep; 130(3 Pt 1):433-9. PubMed ID: 7661057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concept of an antiatherosclerotic efficacy of calcium entry blockers. INTACT Investigators.
    Jost S; Rafflenbeul W; Deckers J; Wiese B; Hecker H; Nikutta P; Lippolt P; Lichtlen P
    Eur J Epidemiol; 1992 May; 8 Suppl 1():107-19. PubMed ID: 1505647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of high and low osmolar roentgen contrast media in quantitative coronary angiography].
    Jost S; Rafflenbeul W; Gerhardt U; Nellessen U; Reil GH; Hecker H; Lichtlen P
    Z Kardiol; 1988 Dec; 77(12):755-66. PubMed ID: 3074595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International nifedipine trial on antiatherosclerotic therapy (INTACT).
    Lichtlen PR; Nellessen U; Rafflenbeul W; Jost S; Hecker H
    Cardiovasc Drugs Ther; 1987; 1(1):71-9. PubMed ID: 3154311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of coronary artery disease is dependent on anatomic location and diameter. The INTACT investigators.
    Jost S; Deckers JW; Nikutta P; Rafflenbeul W; Wiese B; Hecker H; Lippolt P; Lichtlen PR
    J Am Coll Cardiol; 1993 May; 21(6):1339-46. PubMed ID: 8473639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the vasomotility of epicardial coronary arteries with quantitative coronary angiography.
    Jost S; Rafflenbeul W; Lichtlen P
    Z Kardiol; 1989; 78 Suppl 6():143-8. PubMed ID: 2694662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative coronary angiogram analysis: nifedipine retard versus angiotensin-converting enzyme inhibitors (JMIC-B side arm study).
    Shinoda E; Yui Y; Kodama K; Hirayama A; Nonogi H; Haze K; Sumiyoshi T; Hosoda S; Kawai C;
    Hypertension; 2005 Jun; 45(6):1153-8. PubMed ID: 15851624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparable proximal and distal severity of intimal thickening and size of epicardial coronary arteries in transplant arteriopathy of human cardiac allografts.
    Lin H; Wilson JE; Kendall TJ; Radio SJ; Cornhill FJ; Herderick E; Winters GL; Costanzo MR; Porter T; Thieszen SL
    J Heart Lung Transplant; 1994; 13(5):824-33. PubMed ID: 7803423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators.
    Lichtlen PR; Hugenholtz PG; Rafflenbeul W; Hecker H; Jost S; Deckers JW
    Lancet; 1990 May; 335(8698):1109-13. PubMed ID: 1971861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomical progression of coronary artery disease in humans as seen by prospective, repeated, quantitated coronary angiography. Relation to clinical events and risk factors. The INTACT Study Group.
    Lichtlen PR; Nikutta P; Jost S; Deckers J; Wiese B; Rafflenbeul W
    Circulation; 1992 Sep; 86(3):828-38. PubMed ID: 1516195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results.
    Cashin-Hemphill L; Kramsch DM; Azen SP; DeMets D; DeBoer LW; Hwang I; Vailas L; Hirsch LJ; Mack WJ; DeBoer L
    Online J Curr Clin Trials; 1992 Oct; Doc No 26():[9897 words; 83 paragraphs]. PubMed ID: 1343613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducible uniform coronary vasomotor tone with nitrocompounds: prerequisite of quantitative coronary angiographic trials.
    Jost S; Rafflenbeul W; Reil GH; Gulba D; Knop I; Hecker H; Lichtlen PR
    Cathet Cardiovasc Diagn; 1990 Jul; 20(3):168-73. PubMed ID: 2114218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ischemia tolerance of the heart in percutaneous transluminal coronary angioplasty. Controlled study of the effect of isosorbide dinitrate and nifedipine].
    Erbel R; Hüttemann M; Schreiner G; Darius N; Pop T; Meyer J
    Herz; 1987 Aug; 12(4):302-11. PubMed ID: 2958398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.